RBKB director receives 1,624-share stock grant
Rhinebeck Bancorp director Suzanne Loughlin reported a routine equity compensation grant and her existing option holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Rhinebeck Bancorp director Suzanne Loughlin reported a routine equity compensation grant and her existing option holdings. She received 1,624 shares of Common Stock as a grant at $0.00 per share, increasing her direct holdings to 24,559 shares of Common Stock.
The granted shares are restricted stock that will vest in three equal annual installments of 33 1/3% starting on May 26, 2027. She also holds fully vested stock options covering 16,365 shares of Common Stock at an exercise price of $6.57 per share, expiring on August 25, 2030.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,624 | $0.00 | $0.00 |
| holding | Stock Options | -- | -- | -- |
Footnotes (2)
- F1. Shares of restricted stock vest at a rate of 33 1/3% per year commencing on May 26, 2027.
- F2. Stock options are fully vested.
Key Figures
Key Terms
restricted stock financial
Stock Options financial
vest financial
exercise price financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RBKB director Suzanne Loughlin report in this Form 4?
What are the vesting terms of the restricted RBKB stock granted to Loughlin?
What stock options does Suzanne Loughlin hold in Rhinebeck Bancorp?
Was this RBKB Form 4 transaction an open-market buy or sell?
Are Loughlin’s stock options in RBKB vested according to this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.